Deutsche Bank’s Lifecore Biomedical LFCR Stock Holding History

Deutsche Bank’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$93.8K	Buy	25,228 +4,281	+20%	+$29.6K	﹤0.01%	3300
2025 Q4	$171K	Sell	20,947 -5,750	-22%	-$42.5K	﹤0.01%	3088
2025 Q3	$196K	Buy	26,697 +26,213	+5,416%	+$198K	﹤0.01%	3072
2025 Q2	$3.93K	Sell	484 -24,949	-98%	-$168K	﹤0.01%	3539
2025 Q1	$179K	Hold	25,433	–	–	﹤0.01%	3003
2024 Q4	$189K	Sell	25,433 -290,286	-92%	-$1.85M	﹤0.01%	3109
2024 Q3	$1.56M	Hold	315,719	–	–	﹤0.01%	1902
2024 Q2	$1.62M	Hold	315,719	–	–	﹤0.01%	1740
2024 Q1	$1.68M	Hold	315,719	–	–	﹤0.01%	1753
2023 Q4	$1.95M	Buy	+315,719	New	+$2.19M	﹤0.01%	1697
2023 Q3	–	Sell	-101,946	Closed	-$986K	–	3774
2023 Q2	$986K	Sell	101,946 -22,887	-18%	-$140K	﹤0.01%	1995
2023 Q1	$471K	Buy	124,833 +5,712	+5%	+$31.8K	﹤0.01%	2534
2022 Q4	$772K	Buy	119,121 +6,513	+6%	+$53.7K	﹤0.01%	2210
2022 Q3	$1M	Sell	112,608 -1,746	-2%	-$17.8K	﹤0.01%	1961
2022 Q2	$1.14M	Buy	114,354 +100,154	+705%	+$992K	﹤0.01%	2088
2022 Q1	$164K	Sell	14,200 -1,678	-11%	-$18.7K	﹤0.01%	3365
2021 Q4	$176K	Buy	15,878 +832	+6%	+$8.07K	﹤0.01%	3443
2021 Q3	$139K	Sell	15,046 -11,712	-44%	-$127K	﹤0.01%	3745
2021 Q2	$301K	Buy	26,758 +2,261	+9%	+$26.1K	﹤0.01%	3544
2021 Q1	$259K	Sell	24,497 -9,629	-28%	-$108K	﹤0.01%	3494
2020 Q4	$371K	Buy	34,126 +4,910	+17%	+$50.7K	﹤0.01%	3106
2020 Q3	$284K	Buy	29,216 +17,238	+144%	+$164K	﹤0.01%	2999
2020 Q2	$95K	Buy	11,978 +3,765	+46%	+$38.8K	﹤0.01%	3455
2020 Q1	$72K	Sell	8,213 -464	-5%	-$4.83K	﹤0.01%	3388
2019 Q4	$98K	Sell	8,677 -24,583	-74%	-$262K	﹤0.01%	3588
2019 Q3	$360K	Sell	33,260 -869	-3%	-$9.46K	﹤0.01%	2856
2019 Q2	$318K	Buy	34,129 +207	+0.6%	+$2.09K	﹤0.01%	3556
2019 Q1	$415K	Sell	33,922 -2,313	-6%	-$28.2K	﹤0.01%	3564
2018 Q4	$427K	Sell	36,235 -37,633	-51%	-$517K	﹤0.01%	3445
2018 Q3	$1.06M	Buy	73,868 +21,028	+40%	+$291K	﹤0.01%	3288
2018 Q2	$787K	Buy	52,840 +15,612	+42%	+$217K	﹤0.01%	3594
2018 Q1	$483K	Sell	37,228 -23,551	-39%	-$309K	﹤0.01%	3720
2017 Q4	$765K	Buy	60,779 +31,978	+111%	+$404K	﹤0.01%	3377
2017 Q3	$371K	Sell	28,801 -2,476	-8%	-$32.6K	﹤0.01%	3567
2017 Q2	$463K	Buy	31,277 +18,457	+144%	+$257K	﹤0.01%	3492
2017 Q1	$151K	Sell	12,820 -11,644	-48%	-$147K	﹤0.01%	3735
2016 Q4	$336K	Sell	24,464 -95,769	-80%	-$1.33M	﹤0.01%	3405
2016 Q3	$1.61M	Sell	120,233 -43,676	-27%	-$529K	﹤0.01%	2493
2016 Q2	$1.76M	Buy	163,909 +145,689	+800%	+$1.61M	﹤0.01%	2485
2016 Q1	$189K	Sell	18,220 -21,422	-54%	-$235K	﹤0.01%	3687
2015 Q4	$468K	Buy	39,642 +29,453	+289%	+$362K	﹤0.01%	3308
2015 Q3	$117K	Buy	10,189 +2,809	+38%	+$37.2K	﹤0.01%	4033
2015 Q2	$106K	Sell	7,380 -989	-12%	-$14.3K	﹤0.01%	4207
2015 Q1	$115K	Sell	8,369 -5,379	-39%	-$74.3K	﹤0.01%	4059
2014 Q4	$188K	Sell	13,748 -6,258	-31%	-$80.9K	﹤0.01%	4340
2014 Q3	$243K	Buy	20,006 +222	+1%	+$2.77K	﹤0.01%	3958
2014 Q2	$245K	Sell	19,784 -14,688	-43%	-$173K	﹤0.01%	3999
2014 Q1	$384K	Buy	34,472 +8,920	+35%	+$97.8K	﹤0.01%	3501
2013 Q4	$308K	Sell	25,552 -69,610	-73%	-$831K	﹤0.01%	3422
2013 Q3	$1.16M	Buy	95,162 +58,666	+161%	+$819K	﹤0.01%	2862
2013 Q2	$480K	Buy	+36,496	New	+$505K	﹤0.01%	3196

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return